Multimodal Neurodegenerative Disease Subtyping Explained by ChatGPT
- URL: http://arxiv.org/abs/2402.00137v1
- Date: Wed, 31 Jan 2024 19:30:04 GMT
- Title: Multimodal Neurodegenerative Disease Subtyping Explained by ChatGPT
- Authors: Diego Machado Reyes, Hanqing Chao, Juergen Hahn, Li Shen and Pingkun
Yan
- Abstract summary: Alzheimer's disease is the most prevalent neurodegenerative disease.
Current data driven approaches are able to classify the subtypes at later stages of AD or related disorders, but struggle when predicting at the asymptomatic or prodromal stage.
We propose a multimodal framework that uses early-stage indicators such as imaging, genetics and clinical assessments to classify AD patients into subtypes at early stages.
- Score: 15.942849233189664
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Alzheimer's disease (AD) is the most prevalent neurodegenerative disease; yet
its currently available treatments are limited to stopping disease progression.
Moreover, effectiveness of these treatments is not guaranteed due to the
heterogenetiy of the disease. Therefore, it is essential to be able to identify
the disease subtypes at a very early stage. Current data driven approaches are
able to classify the subtypes at later stages of AD or related disorders, but
struggle when predicting at the asymptomatic or prodromal stage. Moreover, most
existing models either lack explainability behind the classification or only
use a single modality for the assessment, limiting scope of its analysis. Thus,
we propose a multimodal framework that uses early-stage indicators such as
imaging, genetics and clinical assessments to classify AD patients into
subtypes at early stages. Similarly, we build prompts and use large language
models, such as ChatGPT, to interpret the findings of our model. In our
framework, we propose a tri-modal co-attention mechanism (Tri-COAT) to
explicitly learn the cross-modal feature associations. Our proposed model
outperforms baseline models and provides insight into key cross-modal feature
associations supported by known biological mechanisms.
Related papers
- Seeing Unseen: Discover Novel Biomedical Concepts via
Geometry-Constrained Probabilistic Modeling [53.7117640028211]
We present a geometry-constrained probabilistic modeling treatment to resolve the identified issues.
We incorporate a suite of critical geometric properties to impose proper constraints on the layout of constructed embedding space.
A spectral graph-theoretic method is devised to estimate the number of potential novel classes.
arXiv Detail & Related papers (2024-03-02T00:56:05Z) - OpenAPMax: Abnormal Patterns-based Model for Real-World Alzheimer's
Disease Diagnosis [9.316162293112738]
We propose an open-set recognition model, OpenAPMax, based on the anomaly pattern to address Alzheimer's disease diagnosis.
We evaluate the performance of the proposed method with recent open-set recognition, where we obtain state-of-the-art results.
arXiv Detail & Related papers (2023-07-03T11:21:09Z) - Leveraging Pretrained Representations with Task-related Keywords for
Alzheimer's Disease Detection [69.53626024091076]
Alzheimer's disease (AD) is particularly prominent in older adults.
Recent advances in pre-trained models motivate AD detection modeling to shift from low-level features to high-level representations.
This paper presents several efficient methods to extract better AD-related cues from high-level acoustic and linguistic features.
arXiv Detail & Related papers (2023-03-14T16:03:28Z) - Benchmarking Continuous Time Models for Predicting Multiple Sclerosis
Progression [46.394865849252696]
Multiple sclerosis is a disease that affects the brain and spinal cord, it can lead to severe disability and has no known cure.
In a recent paper it was shown that disease progression can be predicted effectively using performance outcome measures and demographic data.
We benchmark four continuous time models using a publicly available multiple sclerosis dataset.
We find that the best continuous model is often able to outperform the best benchmarked discrete time model.
arXiv Detail & Related papers (2023-02-15T18:45:32Z) - Pathology Steered Stratification Network for Subtype Identification in
Alzheimer's Disease [7.594681424335177]
Alzheimers disease (AD) is a heterogeneous, multitemporal neurodegenerative disorder characterized by beta-amyloid, pathologic tau, and neurodegeneration.
We propose a novel pathology steered stratification network (PSSN) that incorporates established domain knowledge in AD pathology through a reaction-diffusion model.
arXiv Detail & Related papers (2022-10-12T02:52:00Z) - Integrating Expert ODEs into Neural ODEs: Pharmacology and Disease
Progression [71.7560927415706]
latent hybridisation model (LHM) integrates a system of expert-designed ODEs with machine-learned Neural ODEs to fully describe the dynamics of the system.
We evaluate LHM on synthetic data as well as real-world intensive care data of COVID-19 patients.
arXiv Detail & Related papers (2021-06-05T11:42:45Z) - Modeling Disease Progression in Mild Cognitive Impairment and
Alzheimer's Disease with Digital Twins [0.0]
Digital Twins are simulated clinical records that share baseline data with actual subjects.
We show how Digital Twins simultaneously capture the progression of a number of key endpoints in clinical trials across a broad spectrum of disease severity.
arXiv Detail & Related papers (2020-12-24T22:29:47Z) - Analyzing the effect of APOE on Alzheimer's disease progression using an
event-based model for stratified populations [3.4935855647873293]
We determined the effect of APOE alleles on the disease progression timeline of Alzheimer's disease using a discriminative event-based model (DEBM)
Our secondary aim is to propose and evaluate novel approaches in which we split the different steps of DEBM into group-aspecific and group-specific parts.
The presented models could aid understanding of the disease, and in selecting homogeneous group of presymptomatic subjects at-risk of developing symptoms for clinical trials.
arXiv Detail & Related papers (2020-09-15T14:46:10Z) - Select-ProtoNet: Learning to Select for Few-Shot Disease Subtype
Prediction [55.94378672172967]
We focus on few-shot disease subtype prediction problem, identifying subgroups of similar patients.
We introduce meta learning techniques to develop a new model, which can extract the common experience or knowledge from interrelated clinical tasks.
Our new model is built upon a carefully designed meta-learner, called Prototypical Network, that is a simple yet effective meta learning machine for few-shot image classification.
arXiv Detail & Related papers (2020-09-02T02:50:30Z) - MAGIC: Multi-scale Heterogeneity Analysis and Clustering for Brain
Diseases [3.955454029331185]
We introduce a novel method, MAGIC, to uncover disease heterogeneity by leveraging multi-scale clustering.
We validate MAGIC using simulated heterogeneous neuroanatomical data and demonstrate its clinical potential by exploring the heterogeneity of Alzheimers Disease (AD)
Our results indicate two main subtypes of AD with distinct atrophy patterns that consist of both fine-scale atrophy in the hippocampus as well as large-scale atrophy in cortical regions.
arXiv Detail & Related papers (2020-07-01T23:42:37Z) - A Comprehensive Study on Temporal Modeling for Online Action Detection [50.558313106389335]
Online action detection (OAD) is a practical yet challenging task, which has attracted increasing attention in recent years.
This paper aims to provide a comprehensive study on temporal modeling for OAD including four meta types of temporal modeling methods.
We present several hybrid temporal modeling methods, which outperform the recent state-of-the-art methods with sizable margins on THUMOS-14 and TVSeries.
arXiv Detail & Related papers (2020-01-21T13:12:58Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.